Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer

In Vivo. 1987 Mar-Apr;1(2):113-7.

Abstract

Mice bearing the murine colon carcinomas Colon 38 or Colon 26 were treated with 5-fluorouracil (5 FU) (60 or 100 mg/kg, respectively) weekly for 4 weeks at 08.30 hr or at 18.30 hr. The antitumor effect of treatment at 08.30 hr was significantly better for both types of tumors, but most pronounced for Colon 38. Toxicity was evaluated after administration of 60 mg 5 FU/kg. No thrombocytopenia was observed. Leucopenia was observed after treatment at 18.30 hr. It is concluded that the therapeutic efficacy of 5 FU against murine colon cancer is higher when 5 FU is administered at 08.30 hr.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Circadian Rhythm*
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Drug Administration Schedule
  • Fluorouracil / administration & dosage*
  • Fluorouracil / therapeutic use
  • Fluorouracil / toxicity
  • Leukocyte Count / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Platelet Count / drug effects

Substances

  • Fluorouracil